Trends in the management of atrial fibrillation: A neurologist's perspective (original) (raw)

Prevention of stroke in patients with atrial fibrillation: current strategies and future directions

Gabor Duray

European Heart Journal Supplements, 2008

View PDFchevron_right

Neurointerventional Therapies for Stroke in Atrial Fibrillation

Amit Sharma

Cardiac Electrophysiology Clinics, 2014

View PDFchevron_right

Emerging therapies for stroke prevention in atrial fibrillation

Jeffrey Weitz

European Heart Journal Supplements, 2005

View PDFchevron_right

Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective

John Cairns

Polskie Archiwum Medycyny Wewnętrznej, 2012

View PDFchevron_right

Recent advances in atrial fibrillation and stroke

J. David Spence

Neurological Research, 2015

View PDFchevron_right

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)

Graeme Hankey

Circulation. Cardiovascular quality and outcomes, 2017

View PDFchevron_right

The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation

Rodney Falk

Mayo Clinic Proceedings, 2004

View PDFchevron_right

Stroke Prevention in Atrial Fibrillation: Current Status and Near-Future Directions

Sarah Hussain

The American Journal of Medicine, 2011

View PDFchevron_right

Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation

Abdi Rasekh

Texas Heart Institute Journal

View PDFchevron_right

Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation

Arash Arya

Research in Cardiovascular Medicine, 2012

View PDFchevron_right

Current status of stroke prevention in patients with atrial fibrillation

Philip M Bath

European Heart Journal Supplements, 2005

View PDFchevron_right

Factors In Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients

Mauricio I Scanavacca

Arquivos Brasileiros de Cardiologia, 2016

View PDFchevron_right

Editorial Comment Stroke Prevention in Atrial Fibrillation Trial

John Cairns

2016

View PDFchevron_right

Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants

John Strobeck

Cardiovascular Drugs and Therapy, 2012

View PDFchevron_right

Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs

Maciej Kluk

Cerebrovascular Diseases, 2010

View PDFchevron_right

Contemporary Management of Atrial Fibrillation

Leslie Davis

The Journal for Nurse Practitioners, 2013

View PDFchevron_right

Role of oral anticoagulation in management of atrial fibrillation

Eugene Crystal

Heart, 2004

View PDFchevron_right

Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation

Aung Myo Myat

Expert Review of Cardiovascular Therapy, 2013

View PDFchevron_right

Individualised approaches to thrombo-prophylaxis in atrial fibrillation

John Camm

American Heart Journal, 2015

View PDFchevron_right

Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practice

Philip M Bath

European Heart Journal Supplements, 2005

View PDFchevron_right

New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention

Jafna Cox

The Canadian Journal of Neurological Sciences, 2011

View PDFchevron_right

Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target

John Cairns

Canadian Journal of Cardiology, 2013

View PDFchevron_right

ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives

Carmine Riccio

European heart journal supplements : journal of the European Society of Cardiology, 2017

View PDFchevron_right

New Drugs for Thromboembolic Prevention in Atrial Fibrillation

CARDIOLOGY DEPARTMENT

European Cardiology Review, 2010

View PDFchevron_right

Immediate and Long-term Prevention of Thromboembolism in Atrial Fibrillation (AF)

Joseph Blackshear

1999

View PDFchevron_right

Advancement in antithrombotics for stroke prevention in atrial fibrillation

Michael Ezekowitz

Journal of Interventional Cardiac Electrophysiology, 2008

View PDFchevron_right

Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment

Martin Alpert

Age and Ageing, 2005

View PDFchevron_right

Stroke prevention in atrial fibrillation: Closing the gap

Phil Mendys

American Heart Journal, 2019

View PDFchevron_right

Effectiveness and safety of antithrombotic drugs used for stroke prevention in nonvalvular atrial fibrillation (ESC-FA Study)

Xavier Castells

View PDFchevron_right

Anticoagulation Strategies in Atrial Fibrillation

Sammy Khatib

Reviews in Cardiovascular Medicine, 2012

View PDFchevron_right

In-Depth Review of Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation

Wisit Cheungpasitporn

View PDFchevron_right

The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

Jaime Masjuan

European Journal of Neurology, 2018

View PDFchevron_right

Management of atrial fibrillation

P. Vergara

View PDFchevron_right

Antithrombotic Therapy in Atrial Fibrillation

David García

CHEST Journal, 1993

View PDFchevron_right

Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers

John Fanikos

Journal of Medical Economics, 2013

View PDFchevron_right